The telecom operator had posted a loss of Rs 5,237 crore in the corresponding period of 2019-20
Lower provisioning boosts bottom line; operating profit down 7.74% in Q4FY21 to Rs 885 cr
C K Birla group firm Orient Cement Ltd on Monday reported an over two-fold jump in net profit at Rs 99.87 crore in the fourth quarter ended March 2021. It had posted a net profit of Rs 44.06 crore in the January-March quarter a year ago, Orient Cement said in a BSE filing. Its revenue from operation rose 27.06 per cent to Rs 831.61 crore during the quarter under review as against Rs 654.52 crore in the corresponding period a year earlier. Total expenses were at Rs 680.83 crore in Q4/FY2020-21, up 14.96 per cent as against Rs 654.52 crore. For the fiscal year 2020-21, its net profit rose over two-folds to 214.18 crore. It was Rs 86.58 crore in the previous year. However, its revenue from operations for the fiscal was marginally down by 4.03 per cent at Rs 2,324.08 crore. It was Rs 2,421.79 crore in FY2019-20. The company said that in the wake of the Covid-19 pandemic outbreak and consequent lockdown imposed by the government last year, the manufacturing facilities of the company w
The company's consolidated EBITDA stood at Rs 12,583 crore for the quarter under review
Moody's feels restrictions on movement and lockdowns in several parts of the country will lead to a weaker consumer sentiment and will hit housing and automobile sales
The company has fixed July 16, 2021, as the record date fixed for the purpose of dividend
Second wave could derail strong corporate recovery
The company's performance in Q4FY21 was weighed by moderate YoY growth in India Domestic Formulation (DF)/South Africa and decline in API sales for the quarter
Emkay expects Bharti's underlying momentum to remain intact through mix improvement, resulting in lowest wireless revenue decline of 2 per cent
Here are the best of Business Standard's opinion pieces for Monday
The Covid wave, rising raw material costs can impact near-term sales
Mangalore Chemicals and Fertilisers Ltd on Saturday reported a 38 per cent decline in its net profit at Rs 15.11 crore for the quarter ended March
: Cholamandalam Financial Holdings Ltd has reported a standalone profit of Rs 31.97 crore for the quarter ending March 31, 2021.
Rossari Biotech has posted 37 per cent increase in its revenues from operations during the quarter ended March at Rs 218 crore as against Rs 160 crore in the year-ago period
Drug major Cipla on Friday posted 73 per cent rise in consolidated net profit at Rs 412 crore for the fourth quarter ended March 31, 2021 on the back of robust sales across markets. The Mumbai-based firm had reported a net profit of Rs 238 crore in January-March 2019-20. Total revenue from operations rose to Rs 4,606 crore as compared with Rs 4,376 crore in the same period of 2019-20, Cipla said in a regulatory filing. For the entire 2020-21 fiscal year, the drug maker reported a consolidated net profit of Rs 2,389 crore as against Rs 1,500 crore in the previous year. Total revenue from operations for the last fiscal year rose to Rs 19,160 crore as against Rs 17,132 crore in 2019-20. The company's board recommended a final dividend of Rs 5 per share (face value Rs 2 each) for 2020-21. Cipla shares on Friday ended flat at Rs 904.10 apiece on the BSE.
All verticals posted YoY increase in revenue, while most saw profits grow
Business Standard brings you stories that made the headlines on Friday
L&T's order inflows during the March quarter stood at Rs 50,651 crore, which is a decline of 12 per cent over the year-ago period
The total income during the quarter under review stood at Rs 2,173.56 crore as against Rs 1,664.46 crore in the corresponding quarter a year ago
The company had posted a consolidated net profit of Rs 127.73 crore in the same period previous fiscal